Is the addition of ECG gating to technetium-99m sestamibi SPET of value in the assessment of myocardial viability? An evaluation based on two-dimensional echocardiography following revascularization

被引:25
作者
Gonzalez, P
Massardo, T
Munoz, A
Jofre, J
Rivera, A
Yovanovich, J
Maiers, E
Ayala, F
Humeres, P
Ramirez, A
Arriagada, M
Zavala, A
机构
[1] UNIV CHILE, NUCL MED SECT, SANTIAGO, CHILE
[2] UNIV CHILE, CTR CARDIOVASC, SANTIAGO, CHILE
来源
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1996年 / 23卷 / 10期
关键词
myocardial viability; single-photon emission tomography; myocardial revascularization; dipyridamole; technetium-99m sestamibi;
D O I
10.1007/BF01367586
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The main goal of this study was to evaluate whether the addition of ECG gating to technetium-99m sestamibi single-photon emission tomographic (SPET) perfusion imaging assists the prediction of recovery of regional wall motion abnormalities after revascularization. Thirty-six patients with coronary artery disease were included in the study. All had wall motion abnormalities, and 31 (86%) had a clinical history of myocardial infarction. Coronary artery bypass surgery was performed in 18 patients and angioplasty in the remainder. All underwent EGG-gated and non-gated SPET at rest and after intravenous dipyridamole. Two-dimensional echocardiography was performed at a mean of 27 days before revascularization and at a mean of 69 days following revascularization to assess segmental wall motion changes. Perfusion prior to revascularization was analysed qualitatively and quantitatively on gated and non-gated SPET, and the results compared with those of echocardiography. Bullseye parameters were obtained from a normal database, generated from data in 40 normal volunteers, using dipyridamole EGG-gated and non-gated sestamibi SPET. There was good concordance between gated and non-gated qualitative analysis (79% with kappa=0.65) for normal, viable or necrotic segments. Gated SPET predicted functional recovery in 27 of 35 (77%) segments showing echocardiographic improvement while non-gated SPET did so in 30 of 39 (77%) such segments. Gated SPET predicted no functional recovery in 20 of 45 (44%) segments that did not show improved wall motion after revascularization, while with non-gated SPET the figure was 18 of 51 (35%). The positive predictive values of gated and non-gated SPET with regard to the recovery of wall motion following revascularization were 52% and 48%, while the negative predictive values were 71% and 67%, respectively. Tc-99m-sestamibi had a low predictive value for recovery of function if visual assessment was used in the analysis of SPET data. Quantitative bullseye sestamibi parameters (defect extension and severity, reversibility and percentage change in extension), from gated or non-gated studies, appear best to distinguish which segments will display improved motility on the echocardiogram after revascularization. The addition of ECG gating does not significantly increase the predictive value of SPET imaging with regard to recovery of function.
引用
收藏
页码:1315 / 1322
页数:8
相关论文
共 27 条
[1]  
ALTEHOEFER C, 1994, J NUCL MED, V35, P569
[2]  
AVERY P, 1993, BRIT HEART J, V70, P22
[3]  
BISI G, 1995, J NUCL MED, V36, P1994
[4]  
BONOW RO, 1992, J NUCL MED, V33, P815
[5]   GATED TC-99M SESTAMIBI FOR SIMULTANEOUS ASSESSMENT OF STRESS MYOCARDIAL PERFUSION, POSTEXERCISE REGIONAL VENTRICULAR-FUNCTION AND MYOCARDIAL VIABILITY - CORRELATION WITH ECHOCARDIOGRAPHY AND REST TL-201 SCINTIGRAPHY [J].
CHUA, T ;
KIAT, H ;
GERMANO, G ;
MAURER, G ;
VANTRAIN, K ;
FRIEDMAN, J ;
BERMAN, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (05) :1107-1114
[6]  
CORBETT JR, 1994, J NUCL MED, V35, pP155
[7]  
CUOCOLO A, 1992, J NUCL MED, V33, P505
[8]  
CUOCOLO A, 1994, J NUCL MED, V35, pP153
[9]   MYOCARDIAL VIABILITY IN PATIENTS WITH CHRONIC CORONARY-ARTERY DISEASE - COMPARISON OF TC-99M-SESTAMIBI WITH THALLIUM REINJECTION AND [F-18] FLUORODEOXYGLUCOSE [J].
DILSIZIAN, V ;
ARRIGHI, JA ;
DIODATI, JG ;
QUYYUMI, AA ;
ALAVI, K ;
BACHARACH, SL ;
MARINNETO, JA ;
KATSIYIANNIS, PT ;
BONOW, RO .
CIRCULATION, 1994, 89 (02) :578-587
[10]  
FREEMAN I, 1991, J NUCL MED, V32, P292